H22-hPD-L1
Strain Information
表現型データ
Fig 1. hPD-L1 expression on in vitro cultured cells of H22-hPD-L1
Fig 2. hPD-L1(BALB/c) mice were inoculated with H22-hPD-L1 subcutaneously at 1×106 cells/mouse inoculum for tumor development
Fig 3. hPD-L1 expression in tumors after in vivo growth of H22-hPD-L1 in wild type hPD-L1(BALB/c) mouse. The tumors were collected at day 11 post tumor cell inoculation.
Fig 4. hPD-L1 expression in tumors after in vivo growth of H22-hPD-L1 in wild type hPD-L1(BALB/c) mouse. The tumors were collected at day 21 post tumor cell inoculation.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細